US 11633501
Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof
granted A61KA61K2039/505A61K47/68033
Quick answer
US patent 11633501 (Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K47/68033, A61K47/6869, A61K47/6871